← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Lerner Neil
Officer
Identity: SEC owner CIK matched through an unambiguous cached owner-name crosswalk · Reporting-owner CIK: 0001505148
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 4
- Average purchase
- $19.5K
- Median purchase
- $23.4K
- Gross purchase value
- $78.0K
Companies: Compass Therapeutics, Inc.
4 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-10-02 | Compass Therapeutics, Inc. | CMPX | Officer | $18.4K | Open filing |
| 2026-09-25 | Compass Therapeutics, Inc. | CMPX | Officer | $2.8K | Open filing |
| 2026-04-30 | Compass Therapeutics, Inc. | CMPX | Officer | $28.4K | Open filing |
| 2025-04-08 | Compass Therapeutics, Inc. | CMPX | Officer | $28.4K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 1/3
- Large purchase ≥ $100k
- 0/4
- Cluster buying · 15D
- 2/4
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.